发明名称 |
PROSTATE CANCER DETERMINATION, TREATMENT SELECTION METHOD, PREVENTIVE OR THERAPEUTIC AGENT |
摘要 |
PROBLEM TO BE SOLVED: To provide an effective novel therapy to androgen dependent prostate cancer, and to provide a marker useful for the prediction of the therapeutic effect in androgen independent prostate cancer.SOLUTION: A double-stranded nucleic acid molecule, such as siRNA, which can inhibit the expression of ABHD2 gene is produced, and thereby progression of androgen dependent prostate cancer is inhibited. The therapeutic effect in androgen independent prostate cancer is previously predicted using the expression of ABHD2 gene as a determining marker.SELECTED DRAWING: None |
申请公布号 |
JP2016044130(A) |
申请公布日期 |
2016.04.04 |
申请号 |
JP20140167174 |
申请日期 |
2014.08.20 |
申请人 |
NIHON UNIV |
发明人 |
OBINATA DAISUKE;TAKAHASHI SATORU;INOUE SATOSHI;TAKAYAMA KENICHI |
分类号 |
A61K48/00;A61K31/713;A61P13/08;A61P35/00;C07K14/47;C12N15/09;C12N15/113;C12Q1/68;G01N33/68 |
主分类号 |
A61K48/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|